Proteome Sciences plc (LON:PRM – Get Free Report) shares hit a new 52-week high on Tuesday . The stock traded as high as GBX 5.40 ($0.07) and last traded at GBX 5.30 ($0.07), with a volume of 331024 shares traded. The stock had previously closed at GBX 4.51 ($0.06).
Proteome Sciences Stock Performance
The stock has a market capitalization of £15.64 million, a P/E ratio of -3.84 and a beta of 0.07. The company has a debt-to-equity ratio of -258.66, a quick ratio of 0.37 and a current ratio of 0.20. The business’s fifty day moving average price is GBX 3.92 and its two-hundred day moving average price is GBX 3.28.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Featured Articles
- Five stocks we like better than Proteome Sciences
- Ride Out The Recession With These Dividend Kings
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Home Depot Turns a Corner: New Highs Likely This Year
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
